title: Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis.
abstract: Complement activation is implicated in the development of obesity and insulin resistance, and loss of signaling by the anaphylatoxin C3a prevents obesity-induced insulin resistance in mice. Here we have identified C1q in the classical pathway as required for activation of complement in response to high fat diets. After 8 weeks of high fat diet, wild-type mice became obese and developed glucose intolerance. This was associated with increased apoptotic cell death and accumulation of complement activation products (C3b/iC3b/C3c) in liver and adipose tissue. Previous studies have shown that high fat diet-induced apoptosis is dependent on Bid; here we report that Bid-mediated apoptosis was required for complement activation in adipose and liver. Although C1qa deficiency had no effect on high fat diet-induced apoptosis, accumulation of complement activation products and the metabolic complications of high fat diet-induced obesity were dependent on C1q. When wild-type mice were fed a high fat diet for only 3 days, hepatic insulin resistance was associated with the accumulation of C3b/iC3b/C3c in the liver. Mice deficient in C3a receptor were protected against this early high fat diet-induced hepatic insulin resistance, whereas mice deficient in the negative complement regulator CD55/DAF were more sensitive to the high fat diet. C1qa(-/-) mice were also protected from high fat diet-induced hepatic insulin resistance and complement activation. Evidence of complement activation was also detected in adipose tissue of obese women compared with lean women. Together, these studies reveal an important role for C1q in the classical pathway of complement activation in the development of high fat diet-induced insulin resistance.
authors.affiliation: Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
authors.forename: Antoinette D
authors.initials: AD
authors.lastname: Hillian
authors.forename: Megan R
authors.initials: MR
authors.lastname: McMullen
authors.forename: Becky M
authors.initials: BM
authors.lastname: Sebastian
authors.forename: Sanjoy
authors.initials: S
authors.lastname: Roychowdhury
authors.forename: Sanjoy
authors.initials: S
authors.lastname: Rowchowdhury
authors.forename: Sangeeta R
authors.initials: SR
authors.lastname: Kashyap
authors.forename: Philip R
authors.initials: PR
authors.lastname: Schauer
authors.forename: John P
authors.initials: JP
authors.lastname: Kirwan
authors.forename: Ariel E
authors.initials: AE
authors.lastname: Feldstein
authors.forename: Laura E
authors.initials: LE
authors.lastname: Nagy
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D004041:Dietary Fats / Q000008:administration & dosage*; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism*; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D011951:Receptors, Complement / Q000235:genetics*
chemical_list: D004041:Dietary Fats; D008562:Membrane Glycoproteins; D011951:Receptors, Complement; C032402:complement 1q receptor; D005947:Glucose
keywords: Adipose Tissue; Apoptosis; Complement; Inflammation; Insulin Resistance; Obesity